Tissue Imaging Market

Industry Overview

The Global Tissue Imaging Market size was valued at USD 12.3 billion in 2023 and is expected to grow at a CAGR of 9.4% during the forecast period 2025-2030 anticipated to reach USD 16.7 billion by 2030. This growth of the tissue imaging market can be said, would be a result of factors such as raising application in infectious diseases, oncology, neurological diseases, immunological diseases and cardiovascular diseases; increasing chronic disease incidence, increasing incidence of infectious diseases, rising healthcare spending, and the demand for early detection of diseases. However, in the coming years, the high costs associated with some tissue imaging systems could hamper the growth of the market.

Market Segmentation

Tissue imaging, which is a technique of taking small tissue samples from patients and then usually staining the samples and then visualizing them using either visible or fluorescent light, is the basis of pathology. A skilled pathologist, who will make a diagnosis, will then analyse these photos. This study of images obtained from cells and tissues using microscopy is the basis for much of the field of pathology. The health sector is now focused on developing and applying advanced imaging technologies to improve disease identification and patient outcome prediction objectives.

Insight by Product

Based on product, the Tissue Imaging market is segmented into Consumables and Instruments. Consumables is further divided into Antibodies, Kits, Reagents and Probes. Instruments is further divided into Slide Staining System, Scanner, Tissue Processing system and Other instruments

During the forecast era, the consumables segment is anticipated to rise at the highest growth rate. This is mainly due to their need for large numbers, cost-effectiveness, and ease of use. One of the key factors driving the growth of the consumables market globally is the growing number of reagent rental contracts.

Insight by Technology

Based on Technology, the Tissue Imaging market is segmented into Immunohistochemistry, In Situ Hybridization, Digital Pathology and Workflow Management and Special Staining. The Segment of Immunohistochemistry dominate the tissue diagnostic industry during the forecast period due to the growing prevalence of chronic diseases around the world, where tissue diagnostics often use this technology.

Insight by End-User

Based on end-user, the market is segmented into are Hospitals and Research Laboratories, Pharmaceutical Companies, Contract Research Organizations and Other End Users. Hospitals and Research laboratories dominate the Global Tissue Imaging Market as the major healthcare facilities are visited by patients suffering from a range of health conditions including Alzheimer’s & cancer, that are effective diagnoses via tissue imaging technologies. 

Global Tissue Imaging Market Report Coverage

Industry Dynamics

Growth Drivers

Globally, tissue imaging market has been expanding due to growing investments and funding by governments of various countries and private pharmaceutical companies which  encourage research on personalized medicine. Increasing occurrence of disorders inciting tissue imaging usage along with digital device integration with Imaging Technologies and a decent shifting attention to the value-oriented model of healthcare are some of the vital drivers of the global tissue imaging market. 

Opportunities 

Some of the opportunities for the global tissue imaging market include analytics adoption and artificial intelligence in the market. Also, there is high potential for growth in innovative novel technologies that is technology for spatial transcriptomics. In identifying patients with elevated cardiovascular complication risks, direct visualization/imaging of diseased tissues is helpful, allowing physicians to provide personalized risk-based care. Strategic alliances offer a way to strengthen creativity and market supremacy.

Challenges

The major constraints of the tissue imaging market are reducing research & development funds. Also, high cost & lack of trained professionals are the challenges to the global tissue imaging market. 

Geographical Overview

         a.    North America – U.S.A, Canada
         b.    Europe – Germany, UK, France, Italy, Spain, Rest of Europe
         c.    Asia Pacific (APAC) – India, Japan, China, Rest of APAC
         d.    Rest of the World

The North American region's tissue imaging market dominance is attributed to increasing cancer incidences, increased funding for research and development activities, increasing demand for personalized medicine, technical advancements in proteomics research, and also the presence in the region of major tissue imaging companies. The key factors driving the growth of the tissue diagnostic market in North America are easy accessibility to advanced technology, government initiatives to screen cancer patients, a favourable reimbursement scenario for pathology diagnostic tests, increasing healthcare spending, and high-quality infrastructure for hospitals and clinical laboratories in this area.

Competitive Ananlysis

Synergistic practices such as alliances and collaborations are primarily favoured by the leading contributors to the global tissue imaging market to improve their operations across the globe and to boost their respective dominance. In addition to it, many industry leaders’ partner with start-ups focused on innovations or with emerging players to acquire technology expertise.

Bio-Rad Laboratories, Inc. is an American developer and manufacturer of specialized technological products for the life science research and clinical diagnostics markets. The GelDoc Go Imaging System was introduced by Bio-Rad Laboratories, Inc. to record protein colorimetric bolts, gels & nucleic acids, and stain-free gels & bolts.

Roche (Switzerland) is one of the key players in the market for tissue diagnosis. The organization has a large product range across the world. The firm has retained its leading position in the sector over the years.

Some of the Key Players are Abcam PLC, Bio-Rad Laboratories, Becton, Dickinson, and Company, Fluidigm Corporation, Abbott Laboratories, Agilent Technologies, Biocare Medical, Danaher Corporation, F. Hoffmann-La Roche Ltd., Nikon Corporation, Roche (Switzerland), Danaher (US), Thermo Fisher Scientific (US), Abbott (US), Agilent Technologies (US), ABCAM (UK), Merck KGAA (Germany), Hologic (US), Biomeriux (France), Sakura Fientek Japan (Japan), BioSB (US), Biogenex (US), Cell Signaling Technology (US), Histoline Laboratories (Italy), Slee Medical GMBH (Germany), Amos Scientific Pty Ltd (Australia), Jinhua Yidi Medical Appliance Co.Ltd (China), Medite GMBH (Germany), Cellpath Ltd(UK) and Dipath S.P.A. (Italy)

Recent Developments by Key Players

Bio-Rad Laboratories, Inc. has announced the launch of annexin V conjugated to eight StarBright Dyes that is SBUV400, SBUV795, SBV440, SBV515, SBV790, SBB675, SBB765, SBY800. The new Annexin V StarBright conjugates support detection of early apoptotic cells by flow cytometry, offering an increased range of fluorophore options.

Primary Research

VynZ Research conducts extensive primary research to understand the market dynamics, validate market data and have key opinions from the industry experts. The key profiles approached within the industry includes, CEO, CFO, CTO, President, Vice President, Product Managers, Regional Heads and Others. Also, end user surveys comprising of consumers are also conducted to understand consumer behavior.

The global Electrolyzers Market report offers a comprehensive market segmentation analysis along with estimation for the forecast period 2023–2030.

Segments Covered in the Report

• By Product
  • Antibodies
  • Kits
  • Reagents
  • Probes

• By Technology
  • Immunohistochemistry
  • In Situ Hybridization
  • Digital Pathology and Workflow Management
  • Special Staining

• By End-User
  • Hospitals
  • Research Laboratories
  • Pharmaceutical Companies
  • Contract Research Organizations
  • Other End Users

Region Covered in the Report

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia-Pacific (APAC)
  • China
  • Japan
  • South Korea
  • India
  • Australia
  • Rest of APAC
• Rest of the World
  • Brazil
  • Saudi Arabia
  • South Africa
  • U.A.E
  • Other Countries

Source: VynZ Research

Source: VynZ Research

1.    Research Overview 

        1.1.    The Report Offers
        1.2.    Market Coverage
                1.2.1.    By Product
                1.2.2.    By Technology
                1.2.3.    By Disease
                1.2.4.    By End-Users
        1.3.    Research Phases
        1.4.    Limitations
        1.5.    Research Methodology
                1.5.1.    Data Sources
                        1.5.1.1.    Primary Research
                        1.5.1.2.    Secondary Research
                1.5.2.    Methodology
                        1.5.2.1.    Data Exploration
                        1.5.2.2.    Forecast Parameters
                        1.5.2.3.    Data Validation
                        1.5.2.4.    Assumptions
                1.5.3.    Study Period & Data Reporting Unit

2.    Executive Summary

3.    Industry Overview

        3.1.    Industry Dynamics
                3.1.1.    Market Growth Drivers
                3.1.2.    Market Restraints
                3.1.3.    Key Market Trends
                3.1.4.    Major Opportunities
        3.2.    Industry Ecosystem
                3.2.1.    Porter’s Five Forces Analysis
                3.2.2.    Recent Development Analysis
                3.2.3.    Value Chain Analysis
        3.3.    Competitive Insight
                3.3.1.    Competitive Position of Industry Players
                3.3.2.    Market Attractive Analysis

4.    Global Market Estimate and Forecast

        4.1.    Global Market Overview
        4.2.    Global Market Estimate and Forecast to 2025

5.    Market Segmentation Estimate and Forecast

        5.1.    By Product
                5.1.1.    Consumables
                        5.1.1.1.    Antibodies
                                5.1.1.1.1.    Market Definition
                                5.1.1.1.2.    Market Estimation and Forecast to 2027
                        5.1.1.2.    Kits
                                5.1.1.2.1.    Market Definition
                                5.1.1.2.2.    Market Estimation and Forecast to 2027
                        5.1.1.3.    Reagents
                                5.1.1.3.1.    Market Definition
                                5.1.1.3.2.    Market Estimation and Forecast to 2027
                        5.1.1.4.    Probes
                                5.1.1.4.1.    Market Definition
                                5.1.1.4.2.    Market Estimation and Forecast to 2027
                5.1.2.    Instruments
                        5.1.2.1.    Slide Staining System
                                5.1.2.1.1.    Market Definition
                                5.1.2.1.2.    Market Estimation and Forecast to 2027
                        5.1.2.2.    Scanner
                                5.1.2.2.1.    Market Definition
                                5.1.2.2.2.    Market Estimation and Forecast to 2027
                        5.1.2.3.    Tissue Processing System
                                5.1.2.3.1.    Market Definition
                                5.1.2.3.2.    Market Estimation and Forecast to 2027
                        5.1.2.4.    Other Instruments
                                5.1.2.4.1.    Market Definition
                                5.1.2.4.2.    Market Estimation and Forecast to 2027

        5.2.    By Technology
                5.2.1.    Immunohisto Chemistry
                        5.2.1.1.    Market Definition
                        5.2.1.2.    Market Estimation and Forecast to 2027
                5.2.2.    In Situ Hybridization
                        5.2.2.1.    Market Definition
                        5.2.2.2.    Market Estimation and Forecast to 2027
                5.2.3.    Digital Pathology and Workflow Management
                        5.2.3.1.    Market Definition
                        5.2.3.2.    Market Estimation and Forecast to 2027
                5.2.4.    Special Staining
                        5.2.4.1.    Market Definition
                        5.2.4.2.    Market Estimation and Forecast to 2027
        5.3.    By Disease
                5.3.1.    Breast Cancer
                        5.3.1.1.    Market Definition
                        5.3.1.2.    Market Estimation and Forecast to 2027
                5.3.2.    Gastric Cancer
                        5.3.2.1.    Market Definition
                        5.3.2.2.    Market Estimation and Forecast to 2027
                5.3.3.    Lymphoma
                        5.3.3.1.    Market Definition
                        5.3.3.2.    Market Estimation and Forecast to 2027
                5.3.4.    Prostate Cancer
                        5.3.4.1.    Market Definition
                        5.3.4.2.    Market Estimation and Forecast to 2027
                5.3.5.    Non-Small Cell Lung Cancer
                        5.3.5.1.    Market Definition
                        5.3.5.2.    Market Estimation and Forecast to 2027
        5.4.    By End-Users
                5.4.1.    Hospitals
                        5.4.1.1.    Market Definition
                        5.4.1.2.    Market Estimation and Forecast to 2027
                5.4.2.    Research Laboratories
                        5.4.2.1.    Market Definition
                        5.4.2.2.    Market Estimation and Forecast to 2027
                5.4.3.    Pharmaceutical Companies
                        5.4.3.1.    Market Definition
                        5.4.3.2.    Market Estimation and Forecast to 2027
                5.4.4.    Contract Research Organizations
                        5.4.4.1.    Market Definition
                        5.4.4.2.    Market Estimation and Forecast to 2027

6.    North America Market Estimate and Forecast

        6.1.    By Product
        6.2.    By Technology
        6.3.    By Disease
        6.4.    End-Users
        6.5.    By Country
                6.5.1.    U.S. Market Estimate and Forecast
                6.5.2.    Canada Market Estimate and Forecast
                6.5.3.    Mexico Market Estimate and Forecast

7.    Europe Market Estimate and Forecast

        7.1.    By Product
        7.2.    By Technology
        7.3.    By Disease
        7.4.    End-Users
        7.5.    By Country
                7.5.1.    Germany Market Estimate and Forecast
                7.5.2.    France Market Estimate and Forecast
                7.5.3.    U.K. Market Estimate and Forecast
                7.5.4.    Italy Market Estimate and Forecast
                7.5.5.    Spain Market Estimate and Forecast
                7.5.6.    Russia Market Estimate and Forecast
                7.5.7.    Rest of Europe Market Estimate and Forecast

8.    Asia-Pacific Market Estimate and Forecast

        8.1.    By Product
        8.2.    By Technology
        8.3.    By Disease
        8.4.    End-Users
        8.5.    By Country
                8.5.1.    China Market Estimate and Forecast
                8.5.2.    Japan Market Estimate and Forecast
                8.5.3.    India Market Estimate and Forecast
                8.5.4.    South Korea Market Estimate and Forecast
                8.5.5.    Rest of Asia-Pacific Market Estimate and Forecast

9.    Rest of the World (RoW) Market Estimate and Forecast

        9.1.    By Product
        9.2.    By Technology
        9.3.    By Disease
        9.4.    End-Users
        9.5.    By Country
                9.5.1.    Brazil Market Estimate and Forecast
                9.5.2.    Saudi Arabia Market Estimate and Forecast
                9.5.3.    South Africa Market Estimate and Forecast
                9.5.4.    U.A.E. Market Estimate and Forecast
                9.5.5.    Other Countries Market Estimate and Forecast

10.    Company Profiles

        10.1.    Abcam PLC
                    10.1.1.    Snapshot
                    10.1.2.    Overview
                    10.1.3.    Offerings
                    10.1.4.    Financial Insight
                    10.1.5.    Recent Developments
        10.2.    Bio-Rad Laboratories
                    10.2.1.    Snapshot
                    10.2.2.    Overview
                    10.2.3.    Offerings
                    10.2.4.    Financial Insight
                    10.2.5.    Recent Developments
        10.3.    Becton, Dickinson, and Company
                    10.3.1.    Snapshot
                    10.3.2.    Overview
                    10.3.3.    Offerings
                    10.3.4.    Financial Insight
                    10.3.5.    Recent Developments
        10.4.    Fluidigm Corporation
                    10.4.1.    Snapshot
                    10.4.2.    Overview
                    10.4.3.    Offerings
                    10.4.4.    Financial Insight
                    10.4.5.    Recent Developments
        10.5.    Abbott Laboratories
                    10.5.1.    Snapshot
                    10.5.2.    Overview
                    10.5.3.    Offerings
                    10.5.4.    Financial Insight
                    10.5.5.    Recent Developments
        10.6.    Agilent Technologies
                    10.6.1.    Snapshot
                    10.6.2.    Overview
                    10.6.3.    Offerings
                    10.6.4.    Financial Insight
                    10.6.5.    Recent Developments
        10.7.    Biocare Medical
                    10.7.1.    Snapshot
                    10.7.2.    Overview
                    10.7.3.    Offerings
                    10.7.4.    Financial Insight
                    10.7.5.    Recent Developments
        10.8.    Danaher Corporation
                    10.8.1.    Snapshot
                    10.8.2.    Overview
                    10.8.3.    Offerings
                    10.8.4.    Financial Insight
                    10.8.5.    Recent Developments
        10.9.    F. Hoffmann-La Roche Ltd.
                    10.9.1.    Snapshot
                    10.9.2.    Overview
                    10.9.3.    Offerings
                    10.9.4.    Financial Insight
                    10.9.5.    Recent Developments
        10.10.    Nikon Corporation
                    10.10.1.    Snapshot
                    10.10.2.    Overview
                    10.10.3.    Offerings
                    10.10.4.    Financial Insight
                    10.10.5.    Recent Developments
        10.11.    Roche (Switzerland)
                    10.11.1.    Snapshot
                    10.11.2.    Overview
                    10.11.3.    Offerings
                    10.11.4.    Financial Insight
                    10.11.5.    Recent Developments
        10.12.    Danaher (US)
                    10.12.1.    Snapshot
                    10.12.2.    Overview
                    10.12.3.    Offerings
                    10.12.4.    Financial Insight
                    10.12.5.    Recent Developments
        10.13.    Thermo Fisher Scientific (US)
                    10.13.1.    Snapshot
                    10.13.2.    Overview
                    10.13.3.    Offerings
                    10.13.4.    Financial Insight
                    10.13.5.    Recent Developments
        10.14.    Abbott (US)
                    10.14.1.    Snapshot
                    10.14.2.    Overview
                    10.14.3.    Offerings
                    10.14.4.    Financial Insight
                    10.14.5.    Recent Developments
        10.15.    Agilent Technologies (US)
                    10.15.1.    Snapshot
                    10.15.2.    Overview
                    10.15.3.    Offerings
                    10.15.4.    Financial Insight
                    10.15.5.    Recent Developments
        10.16.    ABCAM (UK)
                    10.16.1.    Snapshot
                    10.16.2.    Overview
                    10.16.3.    Offerings
                    10.16.4.    Financial Insight
                    10.16.5.    Recent Developments
        10.17.    Merck KGAA (Germany)
                    10.17.1.    Snapshot
                    10.17.2.    Overview
                    10.17.3.    Offerings
                    10.17.4.    Financial Insight
                    10.17.5.    Recent Developments

11.    Appendix

        11.1.    Exchange Rates
        11.2.    Abbreviations

Note: Financial insight and recent developments of different companies are subject to availability of information in secondary domain.